Anne Rogiers

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Helene Castel

University of Rouen

FRANCE

View details

Lisa Wu

VIP, Associate Professor

Aarhus University

DENMARK

View details

Louis Fox

King's College London

UNITED KINGDOM

View details

Jennifer De Cremer

Vrije Universiteit Brussel

BELGIUM

View details

Jan Bernheim

Vrije Universiteit Brussel

BELGIUM

View details

Wietse Geens

Vrije Universiteit Brussel

BELGIUM

View details

Nathalie Vanlaer

Vrije Universiteit Brussel

BELGIUM

View details

Sven Van Laere

Vrije Universiteit Brussel

BELGIUM

View details

Teofila Seremet

SWITZERLAND

View details

Odrade Gondry

Vrije Universiteit Brussel

BELGIUM

View details

Bart Neyns

Vrije Universiteit Brussel

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anne Rogiers

Research Interests

Explore related searches

Contact this professor

Articles (13)

Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.

Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma module

Emotional Distress, Cognitive Complaints, and Care Needs among Advanced Cancer Survivors Treated with Immune Checkpoint Blockade: A Mixed-Method Study

Cytokine Profile in Patients with Postacute Sequelae of COVID-19

Health-state utilities in long-term advanced melanoma survivors comparable with the general population

Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL

Cancer-related cognitive impairment in non-CNS cancer patients

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab

Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study

Collaborators (11)

Helene Castel

Lisa Wu

Louis Fox

Jennifer De Cremer

Jan Bernheim

Wietse Geens

Nathalie Vanlaer

Sven Van Laere

Teofila Seremet

Odrade Gondry

Bart Neyns

Make your next move.